Cancer News and Research

Latest Cancer News and Research

Breaking the cycle of chronic back pain: new study reveals the power of shifting pain beliefs

Researchers examined whether pain processing therapy involving the reattribution of pain to processes of the brain or mind instead of being indicative of tissue damage or injury could bring pain relief and help improve the recovery process.

3 Oct 2023

Could seaweeds be the superfood and medicine of the future?

Researchers consolidate the diverse nutritional and medicinal benefits of seaweeds, touting their potential in food, nutraceuticals, and pharmaceuticals. The study also highlights challenges and opportunities in industrial applications, calling for more research to optimize extraction and refinement processes.

2 Oct 2023

Ginger shows promise as a natural defense against autoimmune diseases

Comprehensive study reveals that whole ginger extracts have a significant impact on inhibiting neutrophil hyperactivity, a key factor in autoimmune diseases like APS and lupus. Consuming ginger for just a week showed promising results in both animal models and human trials, positioning it as a natural and affordable treatment option for a range of autoimmune disorders.

2 Oct 2023

Cancer pathway process can be streamlined with the adoption of AI and automation

Medicine is a constantly evolving science where small changes can have a huge impact on the lives of patients. When it comes to a cancer diagnosis and treatment, every minute counts. According to European Commission estimates, the cancer incidence by 2040 will impact just over three million people a year.

30 Sep 2023

Cancer cells hijack enhancer DNA to grow faster, study finds

University of Toronto researchers have found that cancer cells can enhance tumor growth by hijacking enhancer DNA normally used when tissues and organs are formed.

29 Sep 2023

Autologous breast reconstruction linked to higher patient satisfaction

Women undergoing autologous breast reconstruction – in which the breast is reconstructed using the patient's own tissues– report higher satisfaction with their breasts at follow-up, compared to those undergoing implant-based reconstruction, reports a study in a special October supplement to Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

29 Sep 2023

Wildling mice provide insights into how microbes affect allergies

The notion that some level of microbial exposure might reduce our risk of developing allergies has arisen over the last few decades and has been termed the hygiene hypothesis.

29 Sep 2023

Larger lymph node threshold helps facilitate better risk stratification and treatment decisions in nasopharyngeal carcinoma

According to the American Journal of Roentgenology (AJR), using a 6-mm threshold, rather than a 5-mm threshold, helps facilitate better risk stratification and treatment decisions in patients with nasopharyngeal carcinoma (NPC).

29 Sep 2023

New drug could transform how doctors treat grade 2 IDH-mutant gliomas

A top UVA Health cancer expert is highlighting how a new drug could transform how doctors treat a brain tumor that typically strikes younger people.

29 Sep 2023

New tau PET radiotracer shows promise for early detection of Alzheimer's disease

A new tau PET radiotracer, 18F-SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimer's disease in its earliest stages, according to research published in the September issue of The Journal of Nuclear Medicine.

29 Sep 2023

Study reveals new insights into how the immune system prevents autoimmunity

Researchers at Stanford University School of Medicine, Yale University School of Medicine, and the Hospital for Special Surgery Research Institute have uncovered new details about how the immune system prevents the production of antibodies that can recognize and damage the body's own, healthy tissues.

29 Sep 2023

Racial disparities in survival rates among patients with multiple myeloma and diabetes

Patients with multiple myeloma, a blood cancer of plasma cells in the bone marrow, who also have diabetes have a reduced overall survival when compared to those without diabetes.

29 Sep 2023

Study shows how tumors "hijack" genetic program used by developing nerves

Cancer tumors "hijack" the genetic program used by developing nerves. This is shown in a study by researchers at Umeå University, Sweden.

29 Sep 2023

Structural racism linked to higher cancer mortality rates among minority populations

Structural racism was associated with increased county-level cancer mortality rates among minority populations compared with whites, according to results presented at the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 29-October 2, 2023.

29 Sep 2023

Hispanic and Latino men in sexual minority groups may lack awareness about HPV-related cancers

A study found multiple gaps in awareness and knowledge about the connection between the human papillomavirus (HPV) and several types of cancer among Hispanic and Latino men who identified as sexual minorities, according to results presented at the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 29-October 2, 2023.

29 Sep 2023

Survey: Racial and ethnic minorities less likely to participate in clinical trials

A survey conducted in one cancer center's catchment area found that while a majority of respondents would be willing to participate in a clinical trial, members of racial and ethnic minority groups were significantly less likely to participate than non-Hispanic whites, according to results presented at the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 29-October 2, 2023.

29 Sep 2023

NCI-sponsored cancer clinical trials become more representative of broader patient population

Compared to the year 2000, a greater proportion of NCI-sponsored early-phase clinical trial participants in 2022 were older, from minority racial/ethnic groups, and lived in historically underrepresented regions of the U.S., according to a study presented at the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 29-October 2, 2023.

29 Sep 2023

Cancer News and Research

Latest Cancer News and Research

Breaking the cycle of chronic back pain: new study reveals the power of shifting pain beliefs

Could seaweeds be the superfood and medicine of the future?

Ginger shows promise as a natural defense against autoimmune diseases

Cancer pathway process can be streamlined with the adoption of AI and automation

Cancer cells hijack enhancer DNA to grow faster, study finds

Autologous breast reconstruction linked to higher patient satisfaction

Wildling mice provide insights into how microbes affect allergies

Larger lymph node threshold helps facilitate better risk stratification and treatment decisions in nasopharyngeal carcinoma

New drug could transform how doctors treat grade 2 IDH-mutant gliomas

New tau PET radiotracer shows promise for early detection of Alzheimer's disease

Study reveals new insights into how the immune system prevents autoimmunity

Racial disparities in survival rates among patients with multiple myeloma and diabetes

Study shows how tumors "hijack" genetic program used by developing nerves

Structural racism linked to higher cancer mortality rates among minority populations

Hispanic and Latino men in sexual minority groups may lack awareness about HPV-related cancers

Survey: Racial and ethnic minorities less likely to participate in clinical trials

NCI-sponsored cancer clinical trials become more representative of broader patient population

Radiotherapy may cause low-grade intestinal inflammation in cancer survivors

The fight against cancer: a comprehensive assessment of preventable and treatable cases

Social security overpayments draw scrutiny and outrage from members of Congress

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in